---
title: "NEUROLOGICAL ONCOLOGY"
date: "2023-02-08"
enableToc: false
---

> [!info]
>
> ğŸŒ±ä¾†è‡ª: [[Pocket Oncology]]

# NEUROLOGICAL ONCOLOGY
Presentation and diagnosis
â€¢ Suspect if new focal neurologic deficits, seizure, memory or balance issues, or evidence of â†‘ intracranial pressure (HA, n/v, vision change)
â€¢ MRI brain for suspected CNS tumors; CT less Se. Consider LP if c/f CNS lymphoma.
Primary CNS tumors
â€¢ Meningioma: histopath. grading (WHO grades). Grade 1 = benign, asx/small â†’ observe. Large or sx â†’ resection if able, radiation if not. Grade 2â€“3 â†’ resection + adjuvant RT (defer if risk of RT complication high and tumor totally resected).
â€¢ Glioma: histopath. grading, Grade 1/2/3: astrocytoma, oligodendroglioma most common; Grade 4: glioblastoma. Grade 3/4 = â€œhigh gradeâ€ (Neuro Oncol 2021;23:1231).
â€¢ Notable testing: 1p/19q, IDH, MGMT methylation (predicts sensitivity to temozolomide)
â€¢ Treatment: max resection as feasible â†’ adjuvant RT + temozolomide â†’ surveillance. Steroids if neuro sx, hold until biopsy if c/f 1Â° CNS lymphoma. Anti-epileptics if seizures.
â€¢ Prognosis based on grade & histology. For glioblastoma, overall survival 12â€“15 mos, based on extent of tumor resection (J Neurosurg 2014;120:31).

* [[low-grade glioma]]
* [[high-grade glioma]]
* [[CNS metastatic disease]]
* [[paraneoplastic syndromes]]
